DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 30 filers reported holding DIAMEDICA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,184 | -40.3% | 4,335 | 0.0% | 0.00% | – |
| Q2 2023 | $18,727 | +182.3% | 4,335 | 0.0% | 0.00% | – |
| Q1 2023 | $6,633 | -3.2% | 4,335 | 0.0% | 0.00% | – |
| Q4 2022 | $6,850 | +37.0% | 4,335 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | -44.4% | 4,335 | 0.0% | 0.00% | – |
| Q2 2022 | $9,000 | -18.2% | 4,335 | 0.0% | 0.00% | – |
| Q1 2022 | $11,000 | -31.2% | 4,335 | 0.0% | 0.00% | – |
| Q4 2021 | $16,000 | -5.9% | 4,335 | 0.0% | 0.00% | – |
| Q3 2021 | $17,000 | -10.5% | 4,335 | 0.0% | 0.00% | – |
| Q2 2021 | $19,000 | -52.5% | 4,335 | 0.0% | 0.00% | – |
| Q1 2021 | $40,000 | -9.1% | 4,335 | 0.0% | 0.00% | – |
| Q4 2020 | $44,000 | +144.4% | 4,335 | 0.0% | 0.00% | – |
| Q3 2020 | $18,000 | – | 4,335 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 470,000 | $1,212,600 | 3.97% |
| Altium Capital Management LP | 496,000 | $1,279,680 | 0.67% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 168,730 | $435,323 | 0.61% |
| Bleichroeder LP | 222,317 | $573,578 | 0.14% |
| Aristides Capital LLC | 106,333 | $274,339 | 0.12% |
| COOPERMAN LEON G | 875,993 | $2,260,062 | 0.12% |
| EAM Investors, LLC | 212,512 | $548,281 | 0.11% |
| CATALYST FINANCIAL PARTNERS LLC | 36,267 | $93,569 | 0.03% |
| Stonebridge Capital Advisors LLC | 20,000 | $51,600 | 0.01% |
| Legend Financial Advisors, Inc. | 1,000 | $2,580 | 0.00% |